source
- PhRMA weighs former Republican lawmakers and Trump administration officials for CEO rolePhRMA, the pharma lobbying group, has been searching for a new chief executive for over four months. The search has focused on candidates with Republican backgrounds, including former members of C…
- Pheast Therapeutics sticks with open R&D despite competitor Antengene moving ahead with anti‑CD24 trialsPheast Therapeutics, a Redwood City biotech founded in 2021, builds on Irv Weissman’s 2019 Nature paper that highlighted the CD24 protein as a promising "don’t eat me" target for cancer immunothera…